- Home
- IKT vs NPWR Comparison
IKT vs NPWR Comparison
Compare IKT & NPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- NPWR
- Stock Information
- Founded
- IKT 2008
- NPWR 2010
- Country
- IKT United States
- NPWR United States
- Employees
- IKT N/A
- NPWR N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- NPWR Industrial Machinery/Components
- Sector
- IKT Health Care
- NPWR Energy
- Exchange
- IKT Nasdaq
- NPWR Nasdaq
- Market Cap
- IKT 140.5M
- NPWR 223.9M
- IPO Year
- IKT 2020
- NPWR N/A
- Fundamental
- Price
- IKT $1.71
- NPWR $2.67
- Analyst Decision
- IKT Buy
- NPWR Buy
- Analyst Count
- IKT 2
- NPWR 2
- Target Price
- IKT $8.00
- NPWR $4.00
- AVG Volume (30 Days)
- IKT 117.1K
- NPWR 1.5M
- Earning Date
- IKT 08-26-2025
- NPWR 08-11-2025
- Dividend Yield
- IKT N/A
- NPWR N/A
- EPS Growth
- IKT N/A
- NPWR N/A
- EPS
- IKT N/A
- NPWR N/A
- Revenue
- IKT N/A
- NPWR $12,000.00
- Revenue This Year
- IKT N/A
- NPWR $308.00
- Revenue Next Year
- IKT N/A
- NPWR $1,811.08
- P/E Ratio
- IKT N/A
- NPWR N/A
- Revenue Growth
- IKT N/A
- NPWR N/A
- 52 Week Low
- IKT $1.12
- NPWR $1.48
- 52 Week High
- IKT $4.20
- NPWR $14.28
- Technical
- Relative Strength Index (RSI)
- IKT 49.23
- NPWR 46.73
- Support Level
- IKT $1.42
- NPWR $2.39
- Resistance Level
- IKT $1.83
- NPWR $2.95
- Average True Range (ATR)
- IKT 0.15
- NPWR 0.28
- MACD
- IKT 0.00
- NPWR -0.02
- Stochastic Oscillator
- IKT 62.11
- NPWR 27.45
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About NPWR NET Power Inc.
NET Power Inc is a clean energy technology company that has developed a novel power generation system, which it refers to as the NET Power Cycle, designed to produce clean, reliable, and low-cost electricity from natural gas while capturing virtually all atmospheric emissions. The company's business model is to license its technology to customers and enable them to build, own, and operate facilities that utilize the Net Power Cycle. It has conducted a successful demonstration of its technology at the La Porte Demonstration Facility and is developing a utility-scale power plant in Texas named Project Permian.